Joined in 2023 
82 
63 About this deal
Surgical removal of large pathological pelvic and/or para-aortic nodes before definitive CTRT is not routinely recommended [IV, D]. Histological tumor grade if required. It needs to be stressed that currently grading remains of uncertain value for squamous cell carcinoma and most subtypes of adenocarcinoma. For adenocarcinoma, the growth pattern (Silva Classification) is recommended. The patient should be discussed in a multidisciplinary team and should be counseled for the advantages and disadvantages of both treatment options (surgery vs radiotherapy) in relation to the individual presence of prognostic factors [IV, A].
All data relevant to the study are included in the article or uploaded as supplementary information.Given the large spectrum of therapeutic options, the multidisciplinary team should recommend a treatment plan according to the patient’s intention, tumor stage, and gestational age of pregnancy at the time of cancer diagnosis. The primary aims of the recommended treatment plan are the oncological safety of the pregnant woman as well as the fetal survival without additional morbidity [V, A]. In patients with cervical advanced cancer, a multidisciplinary approach of physicians, nurses, psychologists, social workers, and community health workers is needed to manage psychosocial and spiritual suffering associated with social stigma deriving from genital disease, malodorous vaginal discharge, etc [IV, A]. Management of patients with T1a1 disease should be tailored to the individual depending on age, desire for fertility preservation, histological type, and the presence or absence of LVSI [III, B].
Patients who are not candidates for extensive surgery should be treated with systemic chemotherapy. Additional treatment can be considered depending of the response [IV, B].Cibula D, Pötter R, Planchamp F et al (2018) The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Virchows Arch 472:919–36 Pathological macroscopic LN (GTV-N) should receive an EBRT boost. Simultaneous integrated boosting using coverage probability planning is recommended. Depending on nodal size and the expected dose contribution from BT a total dose of approximately 60 Gy EQD2 should be the aim of treatment. An alternative treatment option is surgical removal of enlarged nodes. Dykewicz CA (2001) Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clinical Infectious Diseases 33:139–44
In patients with T1a1 tumor regardless of LVSI status and T1a2 tumor LVSI negative with clear margins in the hysterectomy specimen, no additional treatment is recommended [III, B]. The guidelines detailed in this article cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy (SH) specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. A summary of evidence supporting the guidelines is included in Online Supplemental File 1, available online. General RecommendationsEquivocal extrauterine disease should be considered for biopsy to avoid inappropriate treatment [IV, B]. Intra-operative assessment of LN status (evaluated by frozen section) is recommended. Sentinel nodes from both sides of the pelvis and/or any suspicious LN should be sent for intra-operative assessment [III, A]. Quantum Estro Support offers natural estrogen support for women and men.* This top-tier formula contains DIM ( diinydolylmethane ), which helps promote cell cycle activity and healthy estrogen metabolism.* This formula is anchored with comprehensive botanical support in two unique blends: Fem Phyto- Support TM and Estro ProBlend TM for optimal nutritional effect. * Quantum Estro Support is a top choice nutritional formula and is highly recommended as a valuable everyday hormone support supplement.* Quantum Quality Guarantee The addition of pembrolizumab to platinum-based chemotherapy±bevacizumab is recommended in patients with PD-L1 positive tumors, assessed as combined positive score (CPS) of 1 or more [I, A].
The expertly crafted formula enables optimised breakdown and detoxification of estrogen. This gives your body the best chance to lose stubborn lower body fat, regulate hormonal balance and potentially help with the appearance of cellulite. Ingredients The ambition of ESTRO to further reinforce radiation oncology as a core partner in multidisciplinary cancer care, and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, is expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’ Weight gain, severe mood swings, PMS symptoms and even gynecomastia ("man boobs") can be a result of xeno-estrogens or imbalances between estrogen and other hormones for both men and women.
Supplementary Data
Develop and execute comprehensive marketing plans for ESTRO activities, tailoring strategies to specific target audiences, and concurrently manage social media messaging, content schedules, and event planning.
Great Deal 
New Comment